Does NATALIZUMAB Cause Low density lipoprotein increased? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Low density lipoprotein increased have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.0% of all adverse event reports for NATALIZUMAB.
11
Reports of Low density lipoprotein increased with NATALIZUMAB
0.0%
of all NATALIZUMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Low density lipoprotein increased From NATALIZUMAB?
Of the 11 reports, 2 (18.2%) resulted in death, 4 (36.4%) required hospitalization.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
Which NATALIZUMAB Alternatives Have Lower Low density lipoprotein increased Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK